In a first, Alnylam reports success silencing genes in children
September 30, 2020 at 07:03 AM EDT
The data marks the first time a RNA interference drug has been proven to work in pediatric patients.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|